| 中文名 | [4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-吗啉基甲酮 |
|---|---|
| 英文名 | (4-(5-chloro-4-(methylamino)pyrimidin-2-ylamino)-3-methoxyphenyl)(morpholino)methanone |
| 中文别名 |
(4-((5-氯-4-(甲氨基)嘧啶-2-基)氨基)-3-甲氧基苯基)(吗啉代)甲酮
(4-((5-氯-4-(甲氨基)嘧啶-2-基)氨基)-3-甲氧基苯基)(吗啉)甲酮 |
| 英文别名 |
HG-10-,S2948
RK2 INHIBITOR 1 Pkinson’s disease,Leucine-rich reat kinase 2,inhibit,Ser910,BBB,HG 10 102 01,Radiosynthesis,Mouse embryonic fibroblast cells,Mouse Swiss 3T3 cells,MAP kinase interacting kinase,Ser935,MNK,Mitogen activated protein kinase interacting kinase,HG1010201,PET,Inhibitor,MAPK interacting kinase,HEK293 cells,RK2,Positron emission tomoaphy HG-10-, 10 mM in DMSO HG-10 [4-[[5-Chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinylmethanone [4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]amino]-3-Methoxyphenyl]-4-MorpholinylMethanone (4-{[5-Chloro-4-(methylamino)-2-pyrimidinyl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone Methanone, [4-[[5-chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinyl (4-((5-chloro-4- (methylamino)pyrimidin-2-yl)amino)- 3- methoxyphenyl)(morpholino)methano ne |
| 描述 | HG-10-102-01是野生型LRRK2和突变型G2019S抑制剂,IC50分别为23.3 nM和3.2 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
[1]. Choi HG, et al. Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 2012 Aug 9;3(8):658-662. |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 641.1±65.0 °C at 760 mmHg |
| 分子式 | C17H20ClN5O3 |
| 分子量 | 377.825 |
| 闪点 | 341.5±34.3 °C |
| 精确质量 | 377.125458 |
| PSA | 88.61000 |
| LogP | 0.46 |
| 蒸汽压 | 0.0±1.9 mmHg at 25°C |
| 折射率 | 1.652 |
| 储存条件 | 2-8℃ |